+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Drugs Market Research Reports

Gastric Ulcer Treatment Market Report and Forecast 2024-2032 - Product Thumbnail Image

Gastric Ulcer Treatment Market Report and Forecast 2024-2032

  • Report
  • August 2024
  • 240 Pages
  • Global
From
Anal Fistula- Pipeline Insight, 2025 - Product Thumbnail Image

Anal Fistula- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Abdominal Aortic Aneurysm - Pipeline Insight, 2025 - Product Thumbnail Image

Abdominal Aortic Aneurysm - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Opioid-Induced Constipation - Pipeline Insight, 2025 - Product Thumbnail Image

Opioid-Induced Constipation - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cholecystokinin Receptor (CCK) Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Cholecystokinin Receptor (CCK) Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Vasopressin V2 Receptor (V2R) Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Vasopressin V2 Receptor (V2R) Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Vasopressin V1 Receptor (V1R) Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Vasopressin V1 Receptor (V1R) Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Aldose Reductase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Aldose Reductase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Vasopressin Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Vasopressin Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Malabsorption Syndrome Market 2024-2028 - Product Thumbnail Image

Malabsorption Syndrome Market 2024-2028

  • Report
  • July 2024
  • 138 Pages
  • Global
From
Gastrointestinal Diseases Therapeutics Market 2024-2028 - Product Thumbnail Image

Gastrointestinal Diseases Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 174 Pages
  • Global
From
Celiac Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Celiac Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Autoimmune Gastritis - Pipeline Insight, 2025 - Product Thumbnail Image

Autoimmune Gastritis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Functional Constipation - Pipeline Insight, 2025 - Product Thumbnail Image

Functional Constipation - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Abdominal Aneurysms - Pipeline Insight, 2025 - Product Thumbnail Image

Abdominal Aneurysms - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
HIV-associated Lipodystrophy - Pipeline Insight, 2025 - Product Thumbnail Image

HIV-associated Lipodystrophy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chronic Cutaneous Ulcers - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Cutaneous Ulcers - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Radiation-induced Esophagitis - Pipeline Insight, 2025 - Product Thumbnail Image

Radiation-induced Esophagitis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Functional Dyspepsia - Pipeline Insight, 2025 - Product Thumbnail Image

Functional Dyspepsia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Loading Indicator

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists. The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more